In summary, our study delineates a previously unrecognized tumor-suppressive pathway in HCC proliferation, linking PPP1R12B to cell cycle control via PAK2/β-catenin/Cyclin D1 axis. Here, PPP1R12B is linked to hepatocellular carcinoma.